[go: up one dir, main page]

PE56594A1 - Liposomas que contienen hierro (ii) biodisponible y procedimiento para obtenerlos - Google Patents

Liposomas que contienen hierro (ii) biodisponible y procedimiento para obtenerlos

Info

Publication number
PE56594A1
PE56594A1 PE1994245255A PE24525594A PE56594A1 PE 56594 A1 PE56594 A1 PE 56594A1 PE 1994245255 A PE1994245255 A PE 1994245255A PE 24525594 A PE24525594 A PE 24525594A PE 56594 A1 PE56594 A1 PE 56594A1
Authority
PE
Peru
Prior art keywords
solution
iron
added
bioavailable
procedure
Prior art date
Application number
PE1994245255A
Other languages
English (en)
Inventor
Alfredo Adolfo Hager
Paoli Tomas De
Original Assignee
Ferroni Juan Carlos
Lipotech Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferroni Juan Carlos, Lipotech Sa filed Critical Ferroni Juan Carlos
Publication of PE56594A1 publication Critical patent/PE56594A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
    • A23C9/1522—Inorganic additives, e.g. minerals, trace elements; Chlorination or fluoridation of milk; Organic salts or complexes of metals other than natrium or kalium; Calcium enrichment of milk
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dairy Products (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • General Preparation And Processing Of Foods (AREA)

Abstract

SE REFIERE A UNA SOLUCION ACUOSA DE SALES DE HIERRO (II) TALES COMO SULFATO, LACTATO, CITRATO; PUDIENDO CONTENER ADEMAS COBRE, ZINC, COBALTO; ESTABILIZANDOSE CON ACIDO ASCORBICO O ASCORBATOS Y QUE ES MICROENCAPSULADA EN LIPOSOMAS QUE TIENEN UNA MEMBRANA ENVOLVENTE FORMADA POR LECITINA; EL LIPOSOMA PUEDE FORMARSE A PARTIR DE UNA SUSPENSION HOMOGENEA DE FOSFOGLICERIDOS EN AGUA A UNA CONCENTRACION DE 30 g/l A 50 g/l MEDIANTE UN PROCESO DE CONGELACION RAPIDA A -10°C o -15°C Y DESCONGELACION A TEMPERATURA AMBIENTE A LA QUE SE LE ANADE LA SOLUCION ACUOSA DE HIERRO; O A PARTIR DE UNA SOLUCION DE FOSFOGLICERIDOS EN UN SOLVENTE ORGANICO QUE SUFRA EVAPORACION HASTA FORMACION DE UNA PELICULA DELGADA A LA QUE SE LE ANADE LA SOLUCION ACUOSA DE HIERRO BAJO AGITACION A TEMPERATURA AMBIENTE Y SEPARACION DE LOS LIPOSOMAS FORMADOS QUE PUEDEN UTILIZARSE PARA ENRIQUECER UN ALIMENTO TAL COMO LECHE
PE1994245255A 1993-11-09 1994-06-24 Liposomas que contienen hierro (ii) biodisponible y procedimiento para obtenerlos PE56594A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AR32654193 1993-11-09

Publications (1)

Publication Number Publication Date
PE56594A1 true PE56594A1 (es) 1995-01-16

Family

ID=3478880

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1994245255A PE56594A1 (es) 1993-11-09 1994-06-24 Liposomas que contienen hierro (ii) biodisponible y procedimiento para obtenerlos

Country Status (15)

Country Link
US (1) US5534268A (es)
JP (1) JP3059341B2 (es)
KR (1) KR0163216B1 (es)
AU (1) AU676384B2 (es)
BR (1) BR9402539A (es)
CA (1) CA2126648C (es)
CO (1) CO4230051A1 (es)
DE (1) DE4421686C2 (es)
ES (1) ES2083921B1 (es)
FR (1) FR2712190B1 (es)
IT (1) IT1269946B (es)
MY (1) MY111380A (es)
NZ (1) NZ264653A (es)
PE (1) PE56594A1 (es)
UY (1) UY23795A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2735658B1 (fr) * 1995-06-21 1997-09-12 Capsulis Encapsulation de composes a usage alimentaire par des tensioactifs
US5707670A (en) * 1996-08-29 1998-01-13 The Procter & Gamble Company Use of bilayer forming emulsifiers in nutritional compositions comprising divalent mineral salts to minimize off-tastes and interactions with other dietary components
CA2402520A1 (en) * 2000-03-13 2001-09-20 Kenneth Beckman Biocidal methods and compositions
EP1427393A2 (de) * 2000-05-02 2004-06-16 Pharmacept GmbH Wirkstoffhaltige liposome
EP1432403B1 (en) * 2001-10-03 2010-07-28 Celator Pharmaceuticals, Inc. Liposome loading with metal ions
DK1499294T3 (da) * 2002-04-29 2010-12-06 Biotesys Gmbh Polymeriserede, peptid-modificerede lipider som biologiske transportsystemer til mikronæringsstoffer
AU2003257313A1 (en) * 2002-08-13 2004-02-25 Vitalstate Canada Ltd. Multi-phase delivery system comprising a semi-solid matrix phase
KR20040048749A (ko) * 2002-12-04 2004-06-10 곽해수 비타민 ｃ가 함유된 미세캡슐 및 이를 포함하는철분강화우유
CA2521620C (en) 2003-04-11 2012-11-27 Cargill, Incorporated Pellet systems for preparing beverages
JP4950890B2 (ja) * 2004-09-13 2012-06-13 ギリアード サイエンシーズ， インコーポレイテッド 動物に対する鉄の送達
US9445975B2 (en) 2008-10-03 2016-09-20 Access Business Group International, Llc Composition and method for preparing stable unilamellar liposomal suspension
JP2010115151A (ja) * 2008-11-13 2010-05-27 Morinaga Milk Ind Co Ltd 調製粉乳の製造方法
JP4927806B2 (ja) * 2008-11-13 2012-05-09 森永乳業株式会社 調製粉乳の製造方法
IT1398765B1 (it) * 2010-03-02 2013-03-18 A V D Reform S R L Integratore alimentare a base di ferro e procedimento per ottenere detto integratore
RU2453149C1 (ru) * 2010-10-19 2012-06-20 Государственное научное учреждение Всероссийский научно-исследовательский институт пищевых ароматизаторов, кислот и красителей Российской академии сельскохозяйственных наук (ГНУ ВНИИПАКК Россельхозакадемии) Способ получения пищевой добавки - лактата железа
CN104041584A (zh) * 2014-05-26 2014-09-17 张宏宇 一种卵磷脂酸奶
IT201700099627A1 (it) * 2017-09-06 2019-03-06 Anna Angela Barba Produzione di vettori nano-liposomiali incapsulanti ferro altamente biodisponibile con tecnica in continuo.
IT201900019775A1 (it) * 2019-10-25 2021-04-25 Health Progress Italia S R L Composizione nutraceutica liposomiale
WO2022034609A1 (en) * 2020-08-11 2022-02-17 Pravin Nalawade Encapsulated carbonyl iron salt compositions and process thereof
CN112516163A (zh) * 2020-12-21 2021-03-19 西安医学院 一种难溶性三价铁纳米脂质体复合物及其制备方法
IT202200020262A1 (it) 2022-10-03 2024-04-03 Bio Therapic Italia Composizione liposomiale comprendente ferro solfato e suo uso
IT202300007608A1 (it) 2023-04-19 2024-10-19 Bio Therapic Italia Composizione liposomiale comprendente ferro solfato per l’uso nella cura e prevenzione dell’anemia in donne in gravidanza e durante il puerperio

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2481414A (en) * 1945-04-30 1949-09-06 Wisconsin Alumni Res Found Stable fortified milk products and process of preparing same
US4394149A (en) * 1978-02-24 1983-07-19 Szoka Jr Francis C Plant nutriment compositions and method of their application
EP0231261B1 (en) * 1985-07-05 1994-04-06 The Liposome Company, Inc. Multilamellar liposomes having improved trapping efficiencies
JPS62178521A (ja) * 1986-01-30 1987-08-05 Terumo Corp ヘモグロビン含有リポソ−ム
US5320906A (en) * 1986-12-15 1994-06-14 Vestar, Inc. Delivery vehicles with amphiphile-associated active ingredient
US5139803A (en) * 1989-02-09 1992-08-18 Nabisco, Inc. Method and liposome composition for the stabilization of oxidizable substances

Also Published As

Publication number Publication date
ES2083921B1 (es) 1996-12-01
AU676384B2 (en) 1997-03-06
KR950013500A (ko) 1995-06-15
MY111380A (en) 1999-12-31
JPH07233078A (ja) 1995-09-05
DE4421686A1 (de) 1995-05-11
US5534268A (en) 1996-07-09
CA2126648A1 (en) 1995-05-10
CA2126648C (en) 2000-10-10
DE4421686C2 (de) 1997-09-04
FR2712190A1 (fr) 1995-05-19
IT1269946B (it) 1997-04-16
CO4230051A1 (es) 1995-10-19
UY23795A1 (es) 1995-12-22
ITMI941319A0 (it) 1994-06-24
ITMI941319A1 (it) 1995-12-24
FR2712190B1 (fr) 1997-05-16
ES2083921A1 (es) 1996-04-16
JP3059341B2 (ja) 2000-07-04
NZ264653A (en) 1996-06-25
BR9402539A (pt) 1995-07-04
KR0163216B1 (ko) 1998-12-01
AU7768294A (en) 1995-05-18

Similar Documents

Publication Publication Date Title
PE56594A1 (es) Liposomas que contienen hierro (ii) biodisponible y procedimiento para obtenerlos
Good Activation of the Hill reaction by amines
RU95118444A (ru) Способ получения водной дезинфицирующей композиции, дезинфицирующая композиция и двойная упаковка для ее получения
US8211628B2 (en) Compositions and methods for tissue preservation
FI72118B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara oritin- och argininsalter
KR960700079A (ko) 조성물과 이의 용도
MX169758B (es) Procedimiento para preparar un concentrado transparente y estable al almacenamiento
ES2120017T3 (es) Preparacion herbicida, procedimiento para producirla y aditivo activador para su aplicacion en comun.
Sharov et al. Protection of ischemic myocardium by exogenous phosphocreatine: I. Morphologic and phosphorus 31-nuclear magnetic resonance studies
DE3751258D1 (de) Mikrokristalle, die eine aktive Substanz mit phospholipidischer Affinität enthalten und mindestens ein Phospholipid, Verfahren zur Herstellung.
BR112018000124B1 (pt) Composição para ser aplicada como uma solução tópica para uso com superfícies de planta
Levitsky et al. Carnitine: the carrier transporting fatty acyls into mitochondria by means of an electrochemical gradient of H+
Tercafs et al. Adaptation of amphibians to salt water
Robertson et al. The link between charge separation, proton movement and ATPase reactions
CA2011468C (en) Sodium n-acetylneuraminate trihydrate and method for the preparation thereof
DK166961B1 (da) Stabiliseret vandig hydrogenperoxidoploesning og fremgangsmaade til fremstilling deraf
ES2392099T3 (es) Composición soluble en agua que contiene lisofosfatidiletanolamina y lecitina
DK0646042T3 (da) Fremgangsmåde til elektrokemisk fremstilling af dicarboxylsyrer
JPS641798A (en) Detergent composition
JPS57145830A (en) Optical resolution of 2-(4-chlorophenyl)-3-methylbutanoic acid
BR112020001504A2 (pt) composições contendo composto de cobre estabilizado por ácido fosforoso e alquilamina ou alcanolamina para controlar uma doença vegetal causada por um organismo fitopatogênico
FR2819264B1 (fr) Procede de production d'une fraction purifiee de lipoproteines de faible densite de jaune d'oeuf et milieu de conservation incorporant de telles lipoproteines
D'costa et al. In vitro fatty acid oxidation by developing tissues in the adult of the blowfly, Lucilia
JPH0232337A (ja) ハロゲン化銀写真感光材料用処理液の処理方法及び処理装置
ATE77091T1 (de) Verfahren zur herstellung von alphaaminoalkylphosphons|uren.

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed